Bing Yan

机构：Kunming Children's Hospital, First Affiliated Hospital of Jinan University · ORCID：0000-0001-5430-4761

发表论文 188 篇 · 总被引 2514 次 · h-index 28

代表论文

• Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial (2025 · Nature Medicine · 被引 42)
• Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis (2024 · Frontiers in Immunology · 被引 30)
• New insights into the endotypes of chronic rhinosinusitis in the biologic era (2025 · Journal of Allergy and Clinical Immunology · 被引 29)
• Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps (2025 · JAMA · 被引 23)
• Targeted soluble epoxide hydrolase inhibits M1 macrophage polarization to improve cartilage injury in temporomandibular joint osteoarthritis (2025 · Journal of Translational Medicine · 被引 7)
• A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement (2024 · Frontiers in Pharmacology · 被引 4)